Listed pharmaceutical distributor Neuca signed preliminary deals to buy ACP Pharma for PLN 432 mln from Mediq International, then sell off the retail segment of the firm to private equity firm Penta Investments for PLN 228.7 mln, Neuca said in a market filing.
The deal is subject to regulatory approvals which are to be secured by end-January 2014, the filing reads.
Penta Investments will offer Neuca financing for the retail part of
ACP Pharma that Penta will acquire, then take over the 250 pharmacies
operating under the Mediq brand, Neuca said. Following the transactions
Neuca will have no retail operations, the filing showed.
The final price for ACP Pharma adjusted for the sale of its retail
business will measure PLN 203.3 mln. The final price includes PLN 48.2
mln in net cash in the wholesale segment at end-2012, Neuca noted.
The wholesale part of ACP Pharma is at present the fourth-largest
pharmaceuticals distributor in the country with a 7% share in the
wholesale market in 2012, Neuca said in the press statement.
No comments:
Post a Comment